ID   SLK_HUMAN               Reviewed;        1235 AA.
AC   Q9H2G2; O00211; Q6P1Z4; Q86WU7; Q86WW1; Q92603; Q9NQL0; Q9NQL1;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   05-OCT-2010, entry version 89.
DE   RecName: Full=STE20-like serine/threonine-protein kinase;
DE            Short=STE20-like kinase;
DE            Short=hSLK;
DE            EC=2.7.11.1;
DE   AltName: Full=CTCL tumor antigen se20-9;
DE   AltName: Full=STE20-related serine/threonine-protein kinase;
DE            Short=STE20-related kinase;
DE   AltName: Full=Serine/threonine-protein kinase 2;
GN   Name=SLK; Synonyms=KIAA0204, STK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY,
RP   PHOSPHORYLATION, AND MUTAGENESIS OF LYS-63.
RC   TISSUE=Lung carcinoma;
RX   MEDLINE=20164081; PubMed=10699464; DOI=10.1016/S0167-4889(99)00164-0;
RA   Yamada E., Tsujikawa K., Itoh S., Kameda Y., Kohama Y., Yamamoto H.;
RT   "Molecular cloning and characterization of a novel human STE20-like
RT   kinase, hSLK.";
RL   Biochim. Biophys. Acta 1495:250-262(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   MEDLINE=21143360; PubMed=11149944; DOI=10.1073/pnas.021386498;
RA   Eichmueller S., Usener D., Dummer R., Stein A., Thiel D.,
RA   Schadendorf D.;
RT   "Serological detection of cutaneous T-cell lymphoma-associated
RT   antigens.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:629-634(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   MEDLINE=97191544; PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI.
RT   The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by
RT   analysis of cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [4]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Nomura N.;
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189; SER-340; SER-341;
RP   SER-344; SER-347 AND SER-348, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-755 AND SER-772, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17287340; DOI=10.1073/pnas.0611217104;
RA   Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
RT   "Global proteomic profiling of phosphopeptides using electron transfer
RT   dissociation tandem mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347; SER-348 AND
RP   SER-354, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189; SER-330; SER-347;
RP   SER-348; SER-370; SER-546; THR-569; SER-571; SER-655; SER-777;
RP   SER-779; SER-818; THR-1097 AND SER-1235, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189; SER-347; SER-348;
RP   SER-571; SER-777; SER-779 AND SER-818, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-181; SER-189; SER-340;
RP   SER-341; SER-344; SER-347; SER-348; SER-370; SER-565; THR-569;
RP   SER-571; SER-728; SER-777; SER-779; THR-814; SER-818 AND SER-1229, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-779, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-405; TYR-552; GLN-604; GLY-658;
RP   THR-679; ASN-683 AND ILE-697.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Mediates apoptosis and actin stress fiber dissolution
CC       (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H2G2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H2G2-2; Sequence=VSP_018100;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Highest expression is
CC       found in heart and in skeletal muscle.
CC   -!- PTM: Proteolytically cleaved by caspase-3.
CC   -!- PTM: Autophosphorylated. Phosphorylated upon DNA damage, probably
CC       by ATM or ATR.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 UVR domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH47762.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 611;
CC       Sequence=AAH47885.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 422;
CC       Sequence=AAH64804.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 614;
CC       Sequence=BAA13195.2; Type=Frameshift; Positions=1172;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB002804; BAA19655.1; -; mRNA.
DR   EMBL; AF273048; AAG34908.1; -; mRNA.
DR   EMBL; D86959; BAA13195.2; ALT_SEQ; mRNA.
DR   EMBL; AL360170; CAH70403.1; -; Genomic_DNA.
DR   EMBL; AL138761; CAH70403.1; JOINED; Genomic_DNA.
DR   EMBL; AL360170; CAH70404.1; -; Genomic_DNA.
DR   EMBL; AL138761; CAH70404.1; JOINED; Genomic_DNA.
DR   EMBL; AL138761; CAI12395.1; -; Genomic_DNA.
DR   EMBL; AL360170; CAI12395.1; JOINED; Genomic_DNA.
DR   EMBL; AL138761; CAI12396.1; -; Genomic_DNA.
DR   EMBL; AL360170; CAI12396.1; JOINED; Genomic_DNA.
DR   EMBL; BC047762; AAH47762.1; ALT_SEQ; mRNA.
DR   EMBL; BC047885; AAH47885.1; ALT_SEQ; mRNA.
DR   EMBL; BC064804; AAH64804.1; ALT_SEQ; mRNA.
DR   EMBL; BC111565; AAI11566.1; -; mRNA.
DR   IPI; IPI00022827; -.
DR   IPI; IPI00247439; -.
DR   RefSeq; NP_055535.2; -.
DR   UniGene; Hs.591922; -.
DR   PDB; 2J51; X-ray; 2.10 A; A=19-320.
DR   PDB; 2JFL; X-ray; 2.20 A; A=19-320.
DR   PDB; 2JFM; X-ray; 2.85 A; A=19-320.
DR   PDB; 2UV2; X-ray; 2.30 A; A=19-320.
DR   PDBsum; 2J51; -.
DR   PDBsum; 2JFL; -.
DR   PDBsum; 2JFM; -.
DR   PDBsum; 2UV2; -.
DR   ProteinModelPortal; Q9H2G2; -.
DR   IntAct; Q9H2G2; 8.
DR   MINT; MINT-4539212; -.
DR   STRING; Q9H2G2; -.
DR   PhosphoSite; Q9H2G2; -.
DR   PRIDE; Q9H2G2; -.
DR   Ensembl; ENST00000369755; ENSP00000358770; ENSG00000065613.
DR   GeneID; 9748; -.
DR   KEGG; hsa:9748; -.
DR   UCSC; uc001kxo.1; human.
DR   UCSC; uc001kxp.1; human.
DR   CTD; 9748; -.
DR   GeneCards; GC10P105716; -.
DR   H-InvDB; HIX0009184; -.
DR   HGNC; HGNC:11088; SLK.
DR   HPA; HPA015757; -.
DR   PharmGKB; PA35941; -.
DR   eggNOG; prNOG12060; -.
DR   HOVERGEN; HBG052712; -.
DR   InParanoid; Q9H2G2; -.
DR   OMA; NKLIKSE; -.
DR   OrthoDB; EOG9QC3QQ; -.
DR   PhylomeDB; Q9H2G2; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 36684; -.
DR   PMAP-CutDB; Q9H2G2; -.
DR   ArrayExpress; Q9H2G2; -.
DR   Bgee; Q9H2G2; -.
DR   CleanEx; HS_SLK; -.
DR   Genevestigator; Q9H2G2; -.
DR   GermOnline; ENSG00000065613; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0004518; F:nuclease activity; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0006289; P:nucleotide-excision repair; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR022165; PKK.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR001943; UvrB/C.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF12474; PKK; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50151; UVR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; ATP-binding;
KW   Coiled coil; Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1   1235       STE20-like serine/threonine-protein
FT                                kinase.
FT                                /FTId=PRO_0000233239.
FT   DOMAIN       34    292       Protein kinase.
FT   DOMAIN      875    910       UVR.
FT   NP_BIND      40     48       ATP (By similarity).
FT   COILED      826   1069       Potential.
FT   COILED     1109   1183       Potential.
FT   COMPBIAS     16     19       Poly-Lys.
FT   COMPBIAS    302    652       Glu-rich.
FT   ACT_SITE    155    155       Proton acceptor (By similarity).
FT   BINDING      63     63       ATP (By similarity).
FT   SITE        438    439       Cleavage; by caspase-3 (By similarity).
FT   MOD_RES     181    181       Phosphothreonine.
FT   MOD_RES     189    189       Phosphoserine.
FT   MOD_RES     330    330       Phosphoserine.
FT   MOD_RES     340    340       Phosphoserine.
FT   MOD_RES     341    341       Phosphoserine.
FT   MOD_RES     344    344       Phosphoserine.
FT   MOD_RES     347    347       Phosphoserine.
FT   MOD_RES     348    348       Phosphoserine.
FT   MOD_RES     354    354       Phosphoserine.
FT   MOD_RES     370    370       Phosphoserine.
FT   MOD_RES     546    546       Phosphoserine.
FT   MOD_RES     565    565       Phosphoserine.
FT   MOD_RES     569    569       Phosphothreonine.
FT   MOD_RES     571    571       Phosphoserine.
FT   MOD_RES     655    655       Phosphoserine.
FT   MOD_RES     728    728       Phosphoserine.
FT   MOD_RES     755    755       Phosphothreonine.
FT   MOD_RES     772    772       Phosphoserine.
FT   MOD_RES     777    777       Phosphoserine.
FT   MOD_RES     779    779       Phosphoserine.
FT   MOD_RES     814    814       Phosphothreonine.
FT   MOD_RES     818    818       Phosphoserine.
FT   MOD_RES    1097   1097       Phosphothreonine.
FT   MOD_RES    1229   1229       Phosphoserine.
FT   MOD_RES    1235   1235       Phosphoserine.
FT   VAR_SEQ     929    959       Missing (in isoform 2).
FT                                /FTId=VSP_018100.
FT   VARIANT     405    405       Q -> K (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041080.
FT   VARIANT     552    552       C -> Y (in dbSNP:rs805657).
FT                                /FTId=VAR_041081.
FT   VARIANT     604    604       E -> Q (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041082.
FT   VARIANT     658    658       A -> G (in dbSNP:rs56400929).
FT                                /FTId=VAR_041083.
FT   VARIANT     666    666       G -> E (in dbSNP:rs7071400).
FT                                /FTId=VAR_051666.
FT   VARIANT     679    679       I -> T (in dbSNP:rs34326537).
FT                                /FTId=VAR_041084.
FT   VARIANT     683    683       K -> N (in dbSNP:rs35389916).
FT                                /FTId=VAR_041085.
FT   VARIANT     697    697       T -> I (in dbSNP:rs3740469).
FT                                /FTId=VAR_041086.
FT   MUTAGEN      63     63       K->R: Loss of activity.
FT   CONFLICT      5      5       N -> S (in Ref. 3; BAA13195).
FT   STRAND       25     28
FT   HELIX        30     32
FT   STRAND       34     43
FT   STRAND       46     53
FT   TURN         54     56
FT   STRAND       59     66
FT   STRAND       68     70
FT   HELIX        73     85
FT   STRAND       94    100
FT   STRAND      103    109
FT   HELIX       116    123
FT   HELIX       129    148
FT   HELIX       158    160
FT   STRAND      161    163
FT   STRAND      169    171
FT   HELIX       181    187
FT   HELIX       199    202
FT   TURN        207    209
FT   TURN        212    214
FT   HELIX       215    230
FT   TURN        234    237
FT   HELIX       240    242
FT   HELIX       243    249
FT   HELIX       258    260
FT   HELIX       263    272
FT   TURN        277    279
FT   HELIX       283    286
FT   HELIX       290    292
FT   HELIX       298    307
SQ   SEQUENCE   1235 AA;  142695 MW;  53A43E7CA29B0ED3 CRC64;
     MSFFNFRKIF KLGSEKKKKQ YEHVKRDLNP EDFWEIIGEL GDGAFGKVYK AQNKETSVLA
     AAKVIDTKSE EELEDYMVEI DILASCDHPN IVKLLDAFYY ENNLWILIEF CAGGAVDAVM
     LELERPLTES QIQVVCKQTL DALNYLHDNK IIHRDLKAGN ILFTLDGDIK LADFGVSAKN
     TRTIQRRDSF IGTPYWMAPE VVMCETSKDR PYDYKADVWS LGITLIEMAE IEPPHHELNP
     MRVLLKIAKS EPPTLAQPSR WSSNFKDFLK KCLEKNVDAR WTTSQLLQHP FVTVDSNKPI
     RELIAEAKAE VTEEVEDGKE EDEEEETENS LPIPASKRAS SDLSIASSEE DKLSQNACIL
     ESVSEKTERS NSEDKLNSKI LNEKPTTDEP EKAVEDINEH ITDAQLEAMT ELHDRTAVIK
     ENEREKRPKL ENLPDTEDQE TVDINSVSEG KENNIMITLE TNIEHNLKSE EEKDQEKQQM
     FENKLIKSEE IKDTILQTVD LVSQETGEKE ANIQAVDSEV GLTKEDTQEK LGEDDKTQKD
     VISNTSDVIG TCEAADVAQK VDEDSAEDTQ SNDGKEVVEV GQKLINKPMV GPEAGGTKEV
     PIKEIVEMNE IEEGKNKEQA INSSENIMDI NEEPGTTEGE EITESSSTEE MEVRSVVADT
     DQKALGSEVQ DASKVTTQID KEKKEIPVSI KKEPEVTVVS QPTEPQPVLI PSININSDSG
     ENKEEIGSLS KTETILPPES ENPKENDNDS GTGSTADTSS IDLNLSISSF LSKTKDSGSI
     SLQETRRQKK TLKKTRKFIV DGVEVSVTTS KIVTDSDSKT EELRFLRRQE LRELRFLQKE
     EQRAQQQLNS KLQQQREQIF RRFEQEMMSK KRQYDQEIEN LEKQQKQTIE RLEQEHTNRL
     RDEAKRIKGE QEKELSKFQN MLKNRKKEVI NEVEKAPKEL RKELMKRRKE ELAQSQHAQE
     QEFVQKQQQE LDGSLKKIIQ QQKAELANIE RECLNNKQQL MRAREAAIWE LEERHLQEKH
     QLLKQQLKDQ YFMQRHQLLK RHEKETEQMQ RYNQRLIEEL KNRQTQERAR LPKIQRSEAK
     TRMAMFKKSL RINSTATPDQ DRDKIKQFAA QEEKRQKNER MAQHQKHENQ MRDLQLQCEA
     NVRELHQLQN EKCHLLVEHE TQKLKELDEE HSQELKEWRE KLRPRKKTLE EEFARKLQEQ
     EVFFKMTGES ECLNPSTQSR ISKFYPIPSL HSTGS
//
